|
CN112250759A
|
|
Beta 2-GP1 modified protein and construction method and application thereof
|
|
CN112225816A
|
|
Novel inhalation allergen fusion protein and construction method and application thereof
|
|
CN112225815A
|
|
Milk, wheat, peanut and soybean allergen fusion protein and construction method and application thereof
|
|
CN112250770A
|
|
PR3, MPO and GBM fusion protein, and construction method and application thereof
|
|
CN112250769A
|
|
FTCD and CYP2D6 fusion protein, and construction method and application thereof
|
|
CN112111015A
|
|
PLA2R, C1q and THSD7A fusion protein and construction method and application thereof
|
|
CN111707825A
|
|
Kit for combined detection of tumor markers MCT1 and MCT4, and preparation method and application thereof
|
|
CN111812326A
|
|
Kit for quantitatively detecting content of PD-L1 and PD-1 conjugate
|
|
CN111521777A
|
|
Treatment method for reducing non-specific adsorption in autoimmune antibody detection and kit thereof
|
|
CN111505268A
|
|
Autoimmune antibody detection method
|
|
CN111505283A
|
|
Novel coronavirus antibody detection kit, detection method and application
|
|
CN111423505A
|
|
Ribosome P protein modified protein and preparation method and application thereof
|
|
CN111471672A
|
|
Imine methyl tetrahydrofolate cyclodehydrase truncated protein, preparation method and application thereof
|
|
CN111499765A
|
|
Coronavirus fusion protein and preparation method and application thereof
|
